Diabetes Mellitus study: Telehealth Bridge Visits
Official title ED Diabetes Screening and Outpatient Care - Aim 3
ClinicalTrials.gov ID: NCT05899023
What this study is testing
- What it's testing
- The study aims to learn why some people diagnosed with diabetes in the emergency department do not see a doctor later, and to see if a brief telehealth visit can improve that follow‑up.
- Who it's for
- Adults who are newly diagnosed with diabetes while in the emergency department and have not yet connected with an outpatient doctor.
- What's involved
- Participants may receive a short telehealth (video or phone) visit that links them to a primary‑care doctor, and will answer interview questions about their experience.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
- Residential address in New York City or Long Island
- Primary language is English or Spanish
- Able to provide informed consent
You likely can't join if
- No prior history of diabetes
- No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.